{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["104(2)"],"submitter":["de la Guardia RD"],"funding":["European Research Council","NHLBI NIH HHS"],"journal":["Haematologica"],"pagination":["e54-e58"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6355484"],"repository":["biostudies-literature"],"pubmed_title":["Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in <i>in vivo</i> preclinical models of hematopoietic reconstitution and severe colitis."],"pmcid":["PMC6355484"],"funding_grant_id":["P01 HL107146","646903"],"pubmed_authors":["Gutierrez-Aguera F","Lopez-Millan B","de la Guardia RD","Fuster JL","Anguita E","Sackstein R","Rosu-Myles M","Lavoie J","Zanetti SR","Gonzalez-Rey E","Bueno C","Delgado M","Vives S","Nomdedeu J","Roca-Ho H","Menendez P"],"additional_accession":[]},"is_claimable":false,"name":"Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in <i>in vivo</i> preclinical models of hematopoietic reconstitution and severe colitis.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Feb","modification":"2025-05-18T11:31:25.862Z","creation":"2025-05-18T11:31:25.862Z"},"accession":"S-EPMC6355484","cross_references":{"pubmed":["30237260"],"doi":["10.3324/haematol.2018.196568"]}}